Sign in
4

Changes in Ownership

Silence Therapeutics plc Filed Acc 0001415889-25-000749

Options or other derivatives

  • Director acquired 48,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Davidson Michael H. Director 2025-01-02 Grant or award · Share Option (Right to Buy) +48,000 48,000 D
Loading xslF345X05/form4-01062025_040115.xml…